The American Diabetes Association and other groups are mounting a public health campaign to encourage people with diabetes to get annual eye exams. ADA Chief Scientific and Medical Officer Robert Gabbay, MD, PhD, FACP, explains "leaky blood vessels" and diabetic retinopathy in this first of a four-part video series.
Data presented on a pair of Novartis MS therapies during MSVirtual2020.
Trials taking place fall 2020, the study subset will focus on favipiravir’s potential to reduce viral shedding, diminishing the period of infectiousness.
Workplace stress is an inevitable part of business, but when stress gets out of hand, it’s bad for business and the people who do the work.
The symptoms of the adverse event that led to the pause in Astra Zeneca's COVID-19 vaccine trial are reportedly consistent with transverse myelitis. although the diagnosis has not been confirmed.
As the flu season approaches during the COVID-19 pandemic, Justin Zaghi of Heal says the flu shot is more important than ever this year for a few reasons.
According to a report by L.E.K Consulting, challenges are unlike other industries’, and adoption of artificial intelligence may be slow. Telemedicine accelerated by COVID-19 could drive uptake.
In this week’s episode of Tuning Into the C-Suite podcast, MHE's Briana Contreras spoke with Sebastian Seiguer, CEO of emocha Mobile Health. The two talked about the key health challenges schools are facing as some are reopening across the country for the '20-'21 school year, how telehealth services like emocha are successfully using telehealth to open schools in a Return to Learn program, and paths forward for our nation’s largest school districts.
The New York Times is reporting that a study volunteer in the U.K. developed transverse myelitis.
One code covers additional supplies and clinical time related to safety protocols. The other covers antibody testing.
Pharma makers expect the treatment to be available within a week.
The COVID-19 pandemic is transforming the way the healthcare industry hands payments.
A new study finds people who go on to be diagnosed with MS are more likely to have experienced a significant stressful life event, but the author cautions against jumping to cause-and-effect conclusions.
The medication boasts a statistically significant improvement in overall survival versus placebo.
Study of the quality of life of psoriatic arthritis patients reveals the added burden of skin symptoms.
The letter, “Dentists Fighting Covid” states, in part: “We believe your recommendation is irresponsible, unsubstantiated and dead wrong."
Brent James discusses the long-term consequences of COVID-19.
Four initiatives healthcare operators can implement to help their employees deal with the challenges posed by the pandemic.
Brent James, M.D., M.Stat., the quality and patient safety expert, finds fault with singular focus on COVID-19. Watch James' interview in this part two of three video series.
Pro, college, and high school athletes are seeing increasing numbers of COVID-19 infection and potential heart complications that could be career-ending. Ambulatory cardiac monitoring provider InfoBionic says simple and effective remote cardiac monitoring will save lives—and careers.
Brent James, the quality and patient safety expert, sees excess mortality from lack of care for life-threatening conditions other than COVID-19. Watch James' interview in this part one of three video series.
As MCOs contend with more federal and state-level regulations, below are a few adjustments leaders can make to ensure compliance while Medicaid enrollees increase.
A JAMA Oncology viewpoint argues that the COVID-19 pandemic presents a prime opportunity to make clinical trial design and execution more efficient.
The 2020 meeting, presented in a virtual format from its original host city of Amsterdam, The Netherlands, had lots of important science and a record number of viewers.
Plan sponsors should begin evaluation of PBM performance at least a year before the contract expires, say lawyers with expertise in PBM contracting.
Founders of Medicaid had reason to fear that a state-run program would have limited ability to address the needs of vulnerable populations, say authors of Health Affairs piece.
A study from the European Society of Cardiology answers a question about COVID-19: should patients keep taking well-known heart medications?
This week on Tuning Into the C-Suite, Managed Healthcare Executive's Senior Editor, Peter Wehrwein, spoke with Georgetown's Sabrina Corlette, JD. The two discussed the possible motivations behind health insurer announcing premium credits and discounts in recent weeks and months after their profits (net income, for not-for-profits) swelled due to the drop-off in routine healthcare utilization.
deCODE Genetics researchers find that 90% of those diagnosed with SARS-CoV-2 infection have antibodies to the virus four months later.
One study questions the effectiveness of remdesivir past day 10 while others support its expanded use.
